44 related articles for article (PubMed ID: 32298538)
1. Cutaneous pseudolymphoma successfully treated with dupilumab.
Sugiura S; Nakanishi T; Fujimoto N
Eur J Dermatol; 2023 Jun; 33(3):307-309. PubMed ID: 37594345
[No Abstract] [Full Text] [Related]
2. Cutaneous T-cell pseudolymphoma successfully treated with topical delgocitinib.
Hoshina D; Kimura A
Int J Dermatol; 2024 May; ():. PubMed ID: 38743700
[No Abstract] [Full Text] [Related]
3. Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab.
Lum K; Sanchez R; Zhou C; Sangar S; Dao H; Elsensohn A
JAAD Case Rep; 2024 Apr; 46():95-99. PubMed ID: 38577499
[No Abstract] [Full Text] [Related]
4. Cutaneous Mixed Pseudolymphoma Induced by a Gold Needle Embedded in the Back.
Kim JK; Chun EJ; Yang SY; Kim SS; Kim CW
Ann Dermatol; 2023 Nov; 35(Suppl 2):S357-S358. PubMed ID: 38061743
[No Abstract] [Full Text] [Related]
5. Cutaneous Pseudolymphoma Caused by an Injury with a Metallic Piece of a Mowing Machine Containing Tungsten.
Tokuda M; Kawakami Y; Hirai Y; Tachibana K; Nakagawa Y; Sugihara S; Miyake T; Yamasaki O; Manabe K; Morizane S
Indian J Dermatol; 2023; 68(4):468-470. PubMed ID: 37822384
[No Abstract] [Full Text] [Related]
6. Idiopathic Cutaneous Pseudolymphoma.
Rao AG; Naresh M; Sindhuja B; Pranaya B; N Sindhu V; Shreeja V
Indian J Dermatol; 2022; 67(6):837. PubMed ID: 36998855
[No Abstract] [Full Text] [Related]
7. Combined therapy of local recombinant human interferon α1b injection and acupuncture on verruca vulgaris: a retrospective study.
Chen L; Wu Y; Sun Y; Qiao S; Xiao B; Wang J; An Q; Gao X
Arch Dermatol Res; 2023 Oct; 315(8):2365-2373. PubMed ID: 37179261
[TBL] [Abstract][Full Text] [Related]
8. A case of cutaneous pseudolymphoma with a distinctive appearance treated successfully by intralesional interferon alpha-1b and corticosteroids.
Zeng SH; Chen SY; Tang XY; Wang L
Dermatol Ther; 2020 May; 33(3):e13410. PubMed ID: 32298538
[TBL] [Abstract][Full Text] [Related]
9. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Han B; Liu H; Wang H
Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
[TBL] [Abstract][Full Text] [Related]
10. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
Levy E; Godet J; Cribier B; Lipsker D
Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.
Singletary HL; Selim MA; Olsen E
Arch Dermatol; 2012 May; 148(5):572-4. PubMed ID: 22782150
[No Abstract] [Full Text] [Related]
12. Lymphoma or pseudolymphoma: A report of six cases and review of the literature.
Tian Z; Shiyu Z; Tao W; Li L; Yuehua L; Hongzhong J
Dermatol Ther; 2019 Jul; 32(4):e12807. PubMed ID: 30589489
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Cutaneous Pseudolymphoma: A Systematic Review.
Miguel D; Peckruhn M; Elsner P
Acta Derm Venereol; 2018 Mar; 98(3):310-317. PubMed ID: 29136262
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]